ReviewJournal of clinical pharmacy and therapeutics2020

Safety and tolerability of once-weekly GLP-1 receptor agonists in type 2 diabetes.

Jennifer TrujilloPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.